Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report

Heimbach, Tycho and Kesisoglou, Filippos and Suarez, Sharp and Kakhi, Maziar and Holmstock, Nico and Olivares-Morales, Andres and Pepin, Xavier and Sjögren, Erik and Tsakalozou, Eleftheria and Seo, Paul and Li, Min and Zhang, Xinyuan and Lin, Ho-Pi and Montague, Timothy and Mitra, Amitava and Morris, Denise and Patel, Nikunjkumar (2019) Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report. AAPS Journal, 21 (2). ISSN 15507416

Abstract

This publication summarizes the proceedings of day 2 of a 3-day workshop on “Dissolution and Translational Modeling Strategies Enabling Patient-Centric Product Development.” Patient-centric drug product development from a drug product quality perspective necessitates the establishment of clinically relevant drug product specifications via an in vitro-in vivo link. Modeling and simulation offer a path to establish this link; in this regard, physiologically based modeling has been implemented successfully to support regulatory decision-making and drug product labeling. In this manuscript, case studies of physiologically based biopharmaceutics modeling (PBBM) applied to drug product quality are presented and summarized. These case studies exemplify a possible path to achieve an in vitro-in vivo link and encompass (a) development of biopredictive dissolution methods to support biowaivers, (b) model-informed formulation selection, (c) predicting clinical formulation performance, and (d) defining a safe space for regulatory flexibility via virtual bioequivalence (BE). Workflows for the development and verification of absorption models/PBBM and for the establishment of a safe space using dissolution as an input are described with examples. Breakout session discussions on topics, such as current challenges and some best practices in model development and verification, are included as part of the Supplementary material.

Item Type: Article
Keywords: clinically relevant dissolution specifications IVIVC/IVIVR physiologically based biopharmaceutics modeling (PBBM) safe space virtual bioequivalence
Date Deposited: 09 Jul 2019 00:45
Last Modified: 09 Jul 2019 00:45
URI: https://oak.novartis.com/id/eprint/38458

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.